Viewing Study NCT05690503


Ignite Creation Date: 2025-12-24 @ 7:34 PM
Ignite Modification Date: 2026-01-02 @ 5:58 AM
Study NCT ID: NCT05690503
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-16
First Post: 2022-12-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial
Sponsor: New York State Psychiatric Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module